We are live on ! Find out more
PETX

Aratana Therapeutics, Inc.
PETX

Delisted

PETX was delisted on the 17th of July, 2019.

Back to rankings

103 hedge funds and large institutions have $279M invested in Aratana Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 28 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,283% more call options, than puts

Call options by funds: $166K | Put options by funds: $12K

110% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 10

64% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 28

12% more funds holding

Funds holding: 92 → 103 (+11)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

35% less capital invested

Capital invested by funds: $429M → $279M (-$150M)

Holders
103
Holders Change
+11
Holders Change %
+11.96%
% of All Funds
2.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
21
Increased
46
Reduced
28
Closed
10
Calls
$166K
Puts
$12K
Net Calls
+$154K
Net Calls Change
-$120K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$31M
2
WRF
Waddell & Reed Financial
Kansas
+$17M
3
Jennison Associates
Jennison Associates
New York
+$12.1M
4
PI
Putnam Investments
Massachusetts
+$11.7M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$7.08M

Top Sellers

Rank Fund Capital Flow
1
MAM
MPM Asset Management
Massachusetts
-$16.9M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$5.92M
3
SCM
Sio Capital Management
New York
-$4.48M
4
IHM
Iguana Healthcare Management
New York
-$3.02M
5
HHC
Hutchin Hill Capital
New York
-$2.99M
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$2.31M +$240K +14,200 +5%
Millennium Management
27
Millennium Management
New York
$2M +$889K +52,554 +29%
Deutsche Bank
28
Deutsche Bank
Germany
$1.89M +$617K +36,460 +20%
Lazard Asset Management
29
Lazard Asset Management
New York
$1.66M -$1.3M -76,625 -28%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$1.52M +$68.8K +4,063 +2%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.31M -$169K -9,976 -6%
TCIM
32
TIAA CREF Investment Management
New York
$1.28M -$160K -9,430 -6%
SCM
33
Sio Capital Management
New York
$1.19M -$4.48M -264,582 -65%
HLA
34
Hamilton Lane Advisors
Pennsylvania
$1.03M +$2.06M +121,705 New
MACM
35
March Altus Capital Management
Connecticut
$935K +$1.87M +110,537 New
WCM
36
Westend Capital Management
California
$912K +$575K +34,000 +38%
BIM
37
BlackRock Investment Management
Delaware
$888K -$31.9K -1,883 -2%
T. Rowe Price Associates
38
T. Rowe Price Associates
Maryland
$867K +$1.73M +102,501 New
AP
39
AlpInvest Partners
Netherlands
$846K +$1.69M +100,001 New
UBS AM
40
UBS AM
Illinois
$802K +$1.29M +76,508 +418%
WMSA
41
Weiss Multi-Strategy Advisers
New York
$770K +$16.9K +1,000 +1%
FLAM
42
First Light Asset Management
Minnesota
$701K +$208K +12,291 +17%
Macquarie Group
43
Macquarie Group
Australia
$658K +$1.32M +77,831 New
TA
44
Teachers Advisors
New York
$651K +$2.13K +126 +0.2%
HHC
45
Hutchin Hill Capital
New York
$635K -$2.99M -176,900 -70%
AI
46
Axiom Investors
Connecticut
$462K +$923K +54,570 New
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$456K -$3.38K -200 -0.4%
Charles Schwab
48
Charles Schwab
California
$452K -$122K -7,200 -12%
NFA
49
Nationwide Fund Advisors
Ohio
$431K +$531K +31,348 +160%
Bank of America
50
Bank of America
North Carolina
$367K -$110K -6,478 -13%
1
2
3 4 5

PETX Hedge Fund Activity: Q3 2015 in Review

103 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q3 2015, worth a combined $279M — down 35% from $429M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new PETX positions and 10 closed out — a net gain of 11 holders — while 46 added to existing stakes and 28 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $31M. The largest seller was MPM Asset Management, cutting an estimated $16.9M.

  • 103 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q3 2015, up from 92 in Q2 2015.
  • Funds reported $279M of Aratana Therapeutics, Inc. stock for Q3 2015, down 35% quarter-over-quarter.
  • 21 funds opened new Aratana Therapeutics, Inc. positions in Q3 2015 and 10 closed out, a net change of +11 holders.
  • The largest Aratana Therapeutics, Inc. buyer in Q3 2015 was Wellington Management Group, an estimated $31M added.
  • The largest Aratana Therapeutics, Inc. seller in Q3 2015 was MPM Asset Management, an estimated $16.9M sold.

Based on aggregated 13F filings for Q3 2015.